Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
暂无分享,去创建一个
Reuven Agami | Giulio Maira | G. Maira | Mariette Schrier | Remco Nagel | D. Egan | R. Agami | C. le Sage | M. Farace | S. Ciafrè | A. Mangiola | Remco Nagel | Annunziato Mangiola | N. Mercatelli | Elly M Mesman | C. Anile | Carlos le Sage | Neri Mercatelli | Elly Mesman | Mariette Schrier | Corrado Anile | David A Egan | Silvia Anna Ciafrè | Maria Giulia Farace | Elly M. Mesman | Carlos le Sage
[1] R. Agami,et al. Telomerase-independent Regulation of ATR by Human Telomerase RNA*♦ , 2006, Journal of Biological Chemistry.
[2] R. Bast,et al. The Role of Cyclin-dependent Kinase Inhibitor p27Kip1 in Anti-HER2 Antibody-induced G1 Cell Cycle Arrest and Tumor Growth Inhibition* , 2003, Journal of Biological Chemistry.
[3] D. Hershko,et al. Prognostic role of p27Kip1 deregulation in colorectal cancer , 2006, Cancer.
[4] M. Pagano,et al. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation , 1997, Leukemia.
[5] L. Hengst,et al. p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.
[6] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[7] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[8] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[9] Thomas D. Schmittgen,et al. Expression profiling identifies microRNA signature in pancreatic cancer , 2006, International journal of cancer.
[10] Richard W. Kriwacki,et al. Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.
[11] Y. Oda,et al. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. , 2002, Cancer.
[12] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[13] Anton J. Enright,et al. Zebrafish MiR-430 Promotes Deadenylation and Clearance of Maternal mRNAs , 2006, Science.
[14] M. Dictor,et al. Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. , 2000, Cancer.
[15] M. Pagano,et al. Low expression of p27 and low proliferation index do not correlate in hairy cell leukaemia , 2000, British journal of haematology.
[16] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[17] G. Maira,et al. Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.
[18] M. Pagano,et al. Enhanced Ribosomal Association of p27Kip1 mRNA Is a Mechanism Contributing to Accumulation during Growth Arrest* , 1997, The Journal of Biological Chemistry.
[19] C. Croce,et al. The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] L. Hengst,et al. Translational Control of p27Kip1 Accumulation During the Cell Cycle , 1996, Science.
[21] Mariette Schrier,et al. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.
[22] M. Loda,et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.
[23] C. Croce,et al. MicroRNA deregulation in human thyroid papillary carcinomas. , 2006, Endocrine-related cancer.
[24] R. Bernards,et al. Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.
[25] A. Pasquinelli,et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.
[26] P. Kaldis. Another Piece of the p27Kip1 Puzzle , 2007, Cell.
[27] Y. Oda,et al. Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma , 2002 .
[28] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[29] James M. Roberts,et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.
[30] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[31] Ligang Wu,et al. MicroRNAs direct rapid deadenylation of mRNA. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Massagué,et al. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. , 1995, Cancer research.
[33] James M. Roberts,et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.
[34] K. Welte,et al. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. , 2006, Blood.
[35] R. Plasterk,et al. The diverse functions of microRNAs in animal development and disease. , 2006, Developmental cell.
[36] A. Koff. How to decrease p27Kip1 levels during tumor development. , 2006, Cancer cell.